Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents

Critical Pathways in Cardiology

Volumn 11, Issue 3, 2012, Pages 152-159

  Kersting, Sophia ^a   Grumann, Thorsten ^a   Hummel, Johanna ^a   Hauschke, Dieter ^a   Bode, Christoph ^a   Hehrlein, Christoph ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

chronic kidney disease; drug eluting stent; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

AGED; ANGIOGRAPHY; ARTICLE; BARE METAL STENT; BLEEDING; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEART INFARCTION; HUMAN; KAPLAN MEIER METHOD; KIDNEY FUNCTION; LOADING DRUG DOSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SEPSIS; STENT THROMBOSIS; SURVIVAL; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 84864341371     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e31825d267a     Document Type: Article

References (23)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12. (Pubitemid 36043346)
2. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659-663. (Pubitemid 38392981)
3. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 Suppl 2):S12-154.
4. McCullough PA, Jurkovitz CT, Pergola PE, et al.; for the KEEP Investigators. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007;167:1122-1129. (Pubitemid 46919814)
5. Gruberg L, Dangas G, Mehran R, et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv. 2002;55:66-72. (Pubitemid 34008085)
6. Schoebel FC, Gradaus F, Ivens K, et al. Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography. Heart. 1997;78:337-342. (Pubitemid 27479632)
7. Attallah N, Yassine L, Fisher K, Yee J. Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention. Clin Nephrol. 2005;64:412-418. (Pubitemid 41819400)
8. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insuffciency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003;108:2769-2775. (Pubitemid 37498979)
9. Moses J W, Leon MB, Popma JJ, et al.; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323. (Pubitemid 37186209)
10. Stone G W, Ellis SG, Cox DA, et al.; TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231. (Pubitemid 38067635)
11. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48: 193-202. (Pubitemid 43929240)
12. Braunwald E, Antman EM, Beasley J W, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2000;36:970-1062.
13. Cutlip DE, Windecker S, Mehran R, et al.; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized defnitions. Circulation. 2007;115:2344-2351. (Pubitemid 46685903)
14. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classifcation, and stratifcation. Am J Kidney Dis. 2002;39(2 Suppl 1): S1-266.
15. Latif F, Kleiman NS, Cohen DJ, et al.; EVENT Investigators. In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. JACC Cardiovasc Interv. 2009;2:37-45.
16. Lemos PA, Arampatzis CA, Hoye A, et al. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents. Am J Cardiol. 2005;95:167-172. (Pubitemid 40092079)
17. Saltzman AJ, Stone GW, Claessen BE, et al. Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv. 2011;4:1011-1019.
18. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S16-S23.
19. Best PJ, Steinhubl SR, Berger PB, et al.; CREDO Investigators. The effcacy and safety of short-and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. Am Heart J. 2008;155:687-693.
20. Zhang RY, Ni J W, Zhang JS, et al. Long term clinical outcomes in patients with moderate renal insuffciency undergoing stent based percutaneous coronary intervention. Chin Med J. 2006;119:1176-1181.
21. Rubenstein MH, Harrell LC, Sheynberg B V, Schunkert H, Bazari H, Palacios I F. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation. 2000;102:2966-2972.
22. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and effcacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119:3198-3206.
23. Kuchulakanti PK, Torguson R, Chu W W, et al. Impact of chronic renal in-suffciency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol. 2006;97:792-797.